NCT04646876 is a Phase 3 clinical trial of Magnesium Sulfate in Magnesium Sulphate, sponsored by Osama Mohamed Abdelwahab.

Who is sponsoring NCT04646876?

NCT04646876 is sponsored by Osama Mohamed Abdelwahab.

What drugs are being tested in NCT04646876?

Interventions in NCT04646876: Magnesium Sulfate, Placebo.

What condition does NCT04646876 study?

NCT04646876 studies Magnesium Sulphate, Traumatic Brain Injury, Brain, Injury.

Is NCT04646876 still recruiting?

NCT04646876 is currently completed. Last updated 30 November 2020.

Last reviewed 2020-11-30 · How we verify

NCT04646876

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mgso4 as Neuroprotective in Post Traumatic Brain Injury

Completed Phase 3 Last updated 30 November 2020

What this trial tests

Phase 3 trial testing Magnesium Sulfate in Magnesium Sulphate in 60 participants. Completed in 2 June 2020.

Timeline

2 May 2019

Primary endpoint
12 March 2020

2 June 2020

Quick facts

Lead sponsor	Osama Mohamed Abdelwahab
Phase	Phase 3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	60
Start date	2 May 2019
Primary completion	12 March 2020
Estimated completion	2 June 2020
Sites	1 location across Egypt

Drugs / interventions tested

Magnesium Sulfate — full drug profile →
Placebo

Conditions studied

Magnesium Sulphate — all drugs for Magnesium Sulphate →
Traumatic Brain Injury — all drugs for Traumatic Brain Injury →
Brain — all drugs for Brain →
Injury — all drugs for Injury →

Sponsor

Osama Mohamed Abdelwahab

Who can join

12 and older, any sex, with Magnesium Sulphate or Traumatic Brain Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to assess the potential role of magnesium sulphate (MgSo4) as a neuroprotective agent using the Glasgow outcome scale following moderate and severe traumatic brain injury.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Magnesium Sulfate

Trials testing the same drug.

NCT07478055 — Biomarkers in Management of Post Partum Preeclampsia · Phase 4 · not yet recruiting
NCT06811233 — Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) Therapy, a Phase 2 Randomized Study · Phase 2 · recruiting
NCT06455514 — Post-CA Neuroprotection With Magnesium · Phase 1 · recruiting
NCT06131905 — Magnesium Sulfate as an Adjuvant to Propofol During Consious Sedation in Colonoscopy · Phase 2, PHASE3 · unknown
NCT05343806 — Nifedipine Versus Magnesium Sulfate for Late Preterm Tocolysis · NA · unknown

Other recruiting trials for Magnesium Sulphate

Currently open trials in the same condition.

NCT07139522 — Dexamethasone Versus Magnesium Sulphate as an Adjuvant to Bupivacaine in Ultrasound Guided Erector Spinae Plane Block fo · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04646876 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Osama Mohamed Abdelwahab
Last refreshed: 30 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04646876.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing